About
Neumarker develops AI-powered brain biomarkers to provide objective insights for mental health clinicians and CNS drug developers, aiding in precision treatment and drug development for central nervous system diseases.
Explore Neumarker's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.